Positive Trends Continue for Waters in Q3; Acquity, Mass Spec Drive Revenue Growth | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
For the second quarter in a row, Waters reported year over year revenue growth of 17 percent, which company officials attributed to increased sales for its Acquity UPLC systems and columns and the continuation of a few positive trends.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.